Amer E Alkhalifa

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Blood Brain Barrier

Mild Cognitive Impairment

Monoclonal Antibody

Top Venues

International journal of molecular sciences

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Amer E Alkhalifa, Nour F Al-Ghraiybah, Amal Kaddoumi
Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies. International journal of molecular sciences 25 (3) (2024)
Amer E Alkhalifa, Nour F Al-Ghraiybah, Amal Kaddoumi
Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies. International journal of molecular sciences 25 (3) (2024)
Amer E Alkhalifa, Nour F Al-Ghraiybah, Amal Kaddoumi
Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies. International journal of molecular sciences 25 (3) (2024)
Amer E Alkhalifa, Nour F Al-Ghraiybah, Amal Kaddoumi
Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies. International journal of molecular sciences 25 (3) (2024)
Amer E Alkhalifa, Nour F Al-Ghraiybah, Amal Kaddoumi
Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies. International journal of molecular sciences 25 (3) (2024)
Amer E Alkhalifa, Nour F Al-Ghraiybah, Amal Kaddoumi
Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies. International journal of molecular sciences 25 (3) (2024)
Amer E Alkhalifa, Nour F Al-Ghraiybah, Julia Odum, John G Shunnarah, Nataleigh Austin, Amal Kaddoumi
Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies. International journal of molecular sciences 24 (22) (2023)
Nehad M Ayoub, Dalia R Ibrahim, Amer E Alkhalifa
Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies. Medical oncology (Northwood, London, England) 38 (12) (2021)